Piperacillin / Tazobactam recall: Sterility Concern
PIPERACILLIN / TAZOBACTAM (a) 4.5GM IN NS 100 ML, (b)18GM IN NS 267M, (c) 27GM IN NS 400ML, (d) 3.375 GM IN NS 50ML, (e) 36 GM IN NS 533 ML…
Why was Piperacillin / Tazobactam recalled?
Lack of sterility assurance
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Beyond Use Date: December 25-31, 2022
- Product
- PIPERACILLIN / TAZOBACTAM (a) 4.5GM IN NS 100 ML, (b)18GM IN NS 267M, (c) 27GM IN NS 400ML, (d) 3.375 GM IN NS 50ML, (e) 36 GM IN NS 533 ML…
- Recalling firm
- Sentara Infusion Services
- Quantity
- 78 bags
- Distribution
- Dispensed to Patients Nationwide.
- Recall date
- February 22, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)